Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to determine the Hematologic Improvement (HI) rate during the 12-month study period with rATG (Thymoglobulin), as defined by the IWG and published in 2006 by Cheson and colleagues
Critère d'inclusion
- Low And Intermediate-1 Risk Myelodysplastic Syndrome in adult patients 60 years or younger